Articles

High rate of durable responses with undetectable minimal residual disease with frontline venetoclax and rituximab in young and fit patients with chronic lymphocytic leukemia and an adverse biologic profile: results of the gimema phase II LLC1518 - 'Veritas' study

Hematology, Department of Translational and Precision Medicine, Sapienza University
Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome; GIMEMA Foundation
GIMEMA Foundation
Hematology Department, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan
Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua
Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino
Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato Oncologica (CREO), University of Perugia, Perugia
Department of Hematology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino
GIMEMA Foundation
Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and AOU Maggiore della Carità, Novara
Hematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia
Hematology and Stem Cell Transplantation Unit, Ospedale A. Businco, ARNAS "G. Brotzu", Cagliari
Fondazione Policlinico Universitario A Gemelli, IRCCS
Division of Hematology, Hematology, Arcispedale Santa Maria Nuova, Reggio Emilia
Department of Hematology, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria
Division of Hematology, Azienda Ospedaliera Papardo, Messina
Division of Hematology, Santa Croce e Carle Hospital, Via Michele Coppino 26, 12100 Cuneo
Hematology Section, St. Anna University Hospital, Ferrara
Strategic Research Program on CLL, IRCCS Ospedale San Raffaele and Università Vita- Salute San Raffaele, Milan
Hematology and Transplant Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, University of Eastern Pedemont, Alessandria
Department of Hematology, Pugliese Ciaccio Hospital, Catanzaro
Division of Hematology, Santa Maria delle Croci Hospital, Ravenna
Division of Hematology, Guglielmo da Saliceto Hospital, Piacenza
Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori-IRST, Meldola
ASST Grande Ospedale Metropolitano Niguarda, Milan
Hematology, Mazzoni Hospital, Ascoli Piceno
Hematology Department, Umberto I Hospital, Nocera Inferiore (Salerno)
A.O. Ordine Mauriziano di Torino
Università degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni
University of Bari “Aldo Moro,” Hematology and Stem Cell Transplantation Unit, Department of Emergency and Organ Transplantation, Bari
Hematology, Department of Translational and Precision Medicine, Sapienza University
Hematology and Transplant Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, University of Eastern Pedemont, Alessandria
Hematology Department, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan
Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua
Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino
University of Bari “Aldo Moro,” Hematology and Stem Cell Transplantation Unit, Department of Emergency and Organ Transplantation, Bari
Hematology Department, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan
Hematology, Department of Translational and Precision Medicine, Sapienza University
Hematology, Department of Translational and Precision Medicine, Sapienza University
Hematology, Department of Translational and Precision Medicine, Sapienza University
Hematology, Department of Translational and Precision Medicine, Sapienza University
Hematology, Department of Translational and Precision Medicine, Sapienza University
GIMEMA Foundation
GIMEMA Foundation
GIMEMA Foundation
Hematology Section, St. Anna University Hospital, Ferrara
Hematology, Department of Translational and Precision Medicine, Sapienza University
Haematologica Early view Jan 12, 2023 https://doi.org/10.3324/haematol.2022.282116